Bariatric Surgery Overview

Principles

Definition

Bariatric surgery is a surgical methodology and a significant area of clinical research concerned with procedures designed to induce substantial weight loss and ameliorate metabolic dysfunction in individuals affected by severe obesity. This academic concept encompasses the investigation of diverse surgical techniques, their physiological impacts on energy balance and metabolism, clinical outcomes, long-term complications, and the multidisciplinary management strategies associated with these interventions, representing a critical field in the treatment of obesity and related comorbidities.

Ontological type

Surgical Techniques

Complications and Risks

Indications and Selection

Key developments

Key Figures

Evidence and Safety Foundations era

Walter J. Pories [1] was a pioneering surgeon whose work in the Evidence and Safety Foundations era linked bariatric surgery to diabetes outcomes, with associations at Greenville College [2] and Boston University [3]. His pivotal 1997 paper The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus [4] demonstrated that the procedure could produce durable metabolic benefits, a finding that underpinned early acceptance and shaped how efficacy and safety were weighed. Pories [1] contributed to the era's emphasis on rigorous outcome reporting and long-term follow-up of bariatric procedures. Thus, the gastric bypass findings [4] informed early patient-selection criteria and safety standards that guided subsequent comparative surgical research in this era.

Minimally Invasive Standardization era

Maria L. Collazo–Clavell [1] operated across several institutions during the Minimally Invasive Standardization era (1998-2010). Her key contributions in this era, evidenced by the paper Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery [2], highlighted a post-bypass hyperinsulinemic hypoglycemia syndrome and underscored the need for vigilant surveillance and standardized post-operative protocols. Moreover, Collazo–Clavell [1]'s work helped propel awareness of nesidioblastosis-related hypoglycemia and influenced how centers monitor and respond to this complication during the era. Overall, this work contributed to the rapid diffusion and standardization of recognizing, monitoring, and reporting this bariatric complication across surgical centers.

Metabolic Integration and Durability era

Geltrude Mingrone [1] is a leading bariatric/metabolic surgeon associated with King's College London [3] and King's College School [4] during the Metabolic Integration and Durability era. Her key contributions in this era center on the 2015 Bariatric-metabolic surgery versus conventional medical treatment trial with its five-year follow-up [6], which showcased durable diabetes remission and metabolic benefits, thereby reframing surgical options as integral to chronic disease management. Francesco Rubino [2] is a prominent figure linked with Cornell University [5] and King's College London [3] in this era. His key contributions include co-leading the same randomized trial [6], providing long-term evidence that bariatric-metabolic procedures act as durable metabolic therapies and reshaping metabolic and hepatology practice guidelines.